IGF-IR also contributes to development of hematopoietic malignancies including acute myeloid leukemia (AML), T cell acute lymphoblastic leukemia (T-ALL), multiple myeloma, and CML. The gene discussed is IGF1R; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.